In vivo study of anticancer activity of ginsenoside Rh2-containing arginine-reduced graphene in a mouse model of breast cancer

OBJECTIVE(S): This study aims to evaluate the in vivo anticancer activity of arginine-reduced graphene (Gr-Arg) and ginsenoside Rh2-containing arginine-reduced graphene (Gr-Arg-Rh2). MATERIALS AND METHODS: Thirty-two mice with breast cancer were divided into four groups and treated every three days...

Descripción completa

Detalles Bibliográficos
Autores principales: Farhangfar, Shervin Dokht, Fesahat, Farzaneh, Zare-Zardini, Hadi, Dehghan-Manshadi, Mahdi, Zare, Fateme, Miresmaeili, Seyed Mohsen, Vajihinejad, Maryam, Soltaninejad, Hossein
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mashhad University of Medical Sciences 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9742569/
https://www.ncbi.nlm.nih.gov/pubmed/36544523
http://dx.doi.org/10.22038/IJBMS.2022.66065.14524

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9742569/
https://www.ncbi.nlm.nih.gov/pubmed/36544523
http://dx.doi.org/10.22038/IJBMS.2022.66065.14524

Ejemplares similares